BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 12269862)

  • 1. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.
    Perucca E
    CNS Drugs; 2002; 16(10):695-714. PubMed ID: 12269862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011412. PubMed ID: 29243813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate as a mainstay of therapy for pediatric epilepsy.
    Guerrini R
    Paediatr Drugs; 2006; 8(2):113-29. PubMed ID: 16608372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.
    Löscher W
    CNS Drugs; 2002; 16(10):669-94. PubMed ID: 12269861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug treatment of epilepsy in elderly people: focus on valproic Acid.
    Stephen LJ
    Drugs Aging; 2003; 20(2):141-52. PubMed ID: 12534314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.
    Davis R; Peters DH; McTavish D
    Drugs; 1994 Feb; 47(2):332-72. PubMed ID: 7512905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy.
    de Silva M; MacArdle B; McGowan M; Hughes E; Stewart J; Neville BG; Johnson AL; Reynolds EH
    Lancet; 1996 Mar; 347(9003):709-13. PubMed ID: 8601999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of valproate across the ages. Treatment of epilepsy in children.
    Aldenkamp A; Vigevano F; Arzimanoglou A; Covanis A
    Acta Neurol Scand Suppl; 2006; 184():1-13. PubMed ID: 16776492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analyses.
    Campos MSA; Ayres LR; Morelo MRS; Carizio FAM; Pereira LRL
    Int J Clin Pharm; 2018 Jun; 40(3):589-598. PubMed ID: 29744790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New derivative of 1,2,4-triazole-3-thione (TP427) potentiates the anticonvulsant action of valproate, but not that of carbamazepine, phenytoin or phenobarbital in the mouse tonic-clonic seizure model.
    Łuszczki JJ; Marzeda P; Gut-Lepiech A; Kondrat-Wróbel MW; Wróblewska-Łuczka P; Karwan S; Plech T
    Pharmacol Rep; 2019 Apr; 71(2):299-305. PubMed ID: 30826570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of refractory idiopathic epilepsies.
    Perucca E
    Epilepsia; 2001; 42 Suppl 3():31-5. PubMed ID: 11520320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N; Besag F; Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
    Marson AG; Appleton R; Baker GA; Chadwick DW; Doughty J; Eaton B; Gamble C; Jacoby A; Shackley P; Smith DF; Tudur-Smith C; Vanoli A; Williamson PR
    Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC; Lattanzi S
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD003032. PubMed ID: 30734919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M; Riva R; Albani F; Avoni P; Baruzzi A
    Ther Drug Monit; 2002 Jun; 24(3):332-7. PubMed ID: 12021622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and adverse effects of established and new antiepileptic drugs.
    Mattson RH
    Epilepsia; 1995; 36 Suppl 2():S13-26. PubMed ID: 8784211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary afterdischarge in organotypic hippocampal slice cultures: effects of standard antiepileptic drugs.
    Albus K; Wahab A; Heinemann U
    Epilepsia; 2012 Nov; 53(11):1928-36. PubMed ID: 22812925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures.
    Tudur Smith C; Marson AG; Williamson PR
    Cochrane Database Syst Rev; 2001; (4):CD001769. PubMed ID: 11687121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.
    Serafini A; Gerard E; Genton P; Crespel A; Gelisse P
    CNS Drugs; 2019 Mar; 33(3):195-208. PubMed ID: 30747367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.